Peer Review channel feed

EpimAb nabs Bin Peng from NI­BR; Jef­frey Chodake­witz ex­its Ver­tex; Chris­tiana Sta­moulis is pres­i­dent at Unum

8 years ago

Seek­ing greater gen­der di­ver­si­ty, Al­ny­lam pro­motes four fe­male lead­ers; Paul Hast­ings starts post-On­coMed ca­reer as CEO of stealthy Nkar­ta

8 years ago

Ex-Ax­o­vant COO Mar­i­on Mc­Court lands at Re­gen­eron; GT Bio­phar­ma el­e­vates Shawn Cross to CEO in ex­ec reshuf­fle

8 years ago

CEO Eliot Forster leaves Im­muno­core as the UK biotech uni­corn hunts cash

8 years ago
People

CSO Bill Lund­berg tran­si­tions to ad­vi­sor role at CRISPR Ther­a­peu­tics; Prothena los­es CMO Sarah Noon­berg; Sanofi vet Mark Nut­tall jumps to Kymera

8 years ago

Ken­ji Ya­sukawa takes the reins at Astel­las; Voy­ager hunts for new CEO as Steven Paul goes back to re­search

8 years ago

RNA biotech Arc­turus boots CEO Joseph Payne

8 years ago
People

Hep­tares co-founder Fiona Mar­shall to lead Mer­ck­'s Lon­don re­search hub; Abl­ynx ap­points Robert Friesen as new CFO

8 years ago

Big Phar­ma vet John Hohnek­er takes the reins at Anokion; Hep­tares co-founder Fiona Mar­shall re­signs from par­ent com­pa­ny So­sei

8 years ago

Why did Abl­ynx board chair­man Pe­ter Fell­ner re­sign in wake of Novo's buy­out of­fer?; Am­gen vet Richard Paul­son tapped to run Ipsen North Amer­i­ca

8 years ago

Sanuj Ravin­dran to lead Pelle­Pharm as CEO; Paul Hast­ings leaves On­coMed; Mod­er­na taps John Mendlein as pres­i­dent

8 years ago

Syn­er­gy CEO pass­es torch to CCO Troy Hamil­ton; Pres­i­dent Steven Kaf­ka re­signs from Foun­da­tion; Ab­b­Vie vet John Leonard to helm In­tel­lia

8 years ago

Andy Boy­er joins Te­va ex­o­dus; Achao­gen shuf­fles ex­ec­u­tive line­up

8 years ago

Grail taps Genen­tech vet Jen­nifer Cook as CEO, build­ing ex­pec­ta­tions for 2018

8 years ago
People

No­var­tis on­col­o­gy CEO Bruno St­rig­i­ni is call­ing it quits

8 years ago
People

Cyn­thia Collins ex­its Hu­man Longevi­ty; Sec­tion 32 wel­comes Michael Pelli­ni; Sil­ver­back beefs up its C-suite

8 years ago

Daniel Swish­er leaves an ail­ing Sune­sis and swoops in to lead Jazz Phar­ma­ceu­ti­cals

8 years ago

Lau­ra Shawver hits the ground run­ning, scout­ing new in­vestors for tiny Syn­thorx

8 years ago

Te­va boots its R&D chief; Iron­wood grows the C-suite and In­ter­cept taps new EVP of re­search

8 years ago

Pfiz­er reshuf­fles top ranks with Al­bert Bourla as COO; In­tra-cel­lu­lar nabs No­var­tis vet An­drew Satlin as CMO

8 years ago

An­nal­isa Jenk­in­s' next ca­reer chap­ter takes her back to Eu­rope

8 years ago

Cel­gene's Michael Pehl leaps up to lead role at Im­munomedics; GSK nabs Hal Bar­ron to helm R&D; Aim­mune CEO to step down

8 years ago

Grail vet Ba­jaj aims for some broad in­flu­ence with Fore­site bucks

8 years ago

Peer Re­view: aTyr pro­motes da­ta ex­pert San­jay Shuk­la as CEO

8 years ago
First page Previous page 141516171819 Next page Last page
A service from the Financial Times